Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek - Inventaire

Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats

publicerad i: Molecular Pain

utgivningsår: 2006-01-30

språk: engelska

huvudämne: kronisk smärta

Refererar artiklar 37

Datum

Titel

Författare

2005-02-25

Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10

Leslie Leinwand, Linda R. Watkins, Julie Wieseler-Frank, Leah Spataro, Erin D Milligan
2005-10-01

Intrathecal gene transfer by adeno-associated virus for pain
2005-05-01

Adeno-associated virus vectors in clinical trials
2005-02-01

Immune regulation of central nervous system functions: from sickness responses to pathological pain
2005-04-01

Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10.

Linda R. Watkins, Julie Wieseler-Frank, Raymond A Chavez, Erin D Milligan
2004-07-01

Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective
2004-01-01

Intrathecal catheterization and drug delivery in the rat.
2003-12-01

Glia: a novel drug discovery target for clinical pain
2003-06-01

Gene therapy progress and prospects: gene therapy for the hemophilias
2003-01-01

Adeno-associated virus vectors for therapeutic gene transfer
2003-06-01

Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors
2003-12-01

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
2003-05-01

How to use implantable intrathecal drug delivery systems for refractory cancer pain
2002-03-01

Use of HSV vectors to modify the nervous system
2002-09-01

Electroporation-mediated pain-killer gene therapy for mononeuropathic rats
2002-10-01

Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord

Marc J. Ruitenberg
2002-01-01

Electroporation for direct spinal gene transfer in rats

Chung-Ren Lin
2002-10-01

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival

Thomas J. Smith
2001-08

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
2001-09-01

Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors
2001-04-01

Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion
2000-11-01

Attempted gene therapy for intractable pain: dexamethasone-mediated exogenous control of beta-endorphin secretion in genetically modified cells and intrathecal transplantation
2000-03-01

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system

Joseph Zabner
2000-03-01

Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.
2000-12-01

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
1999-03-01

Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus
1999-10-01

Persistent expression of canine factor IX in hemophilia B canines
1999-05-01

A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain

Andrew J Mannes
1999-11-01

Gene expression along the cerebral-spinal axis after regional gene delivery
1998-05-01

Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration

Brian O'Connell
1995-03-01

Complications of intrathecal opioids and bupivacaine in the treatment of "refractory" cancer pain,Complications of Intrathecal Opioids and Bupivacaine in the Treatment of “Refractory” Cancer Pain
1995-02-01

Retrovirus-mediated expression of an artificial beta-endorphin precursor in primary fibroblasts

Flemming W. Bach, Edward J Bilsky

Artikel - wd:Q25256466

Välkommen till Inventaire

din gemenskap och vänners bibliotek

du är utloggad